The following chart shows the decline of the RX retail market in Italy since 2008, along with the 17% decrease in the average price of RX products per pack in 2015 from 2008. Because of the rise of generics, new chemical entities are often restricted to non-retail channels. ITALY_B_2 Click here to read more articles and interviews from Italy, and to download the latest free pharma report on the country.